Benitec Biopharma Ltd (BNTC): BNTC buy 3.0400 double bottom sidewa...

Reply Private New

Next 10 Prev Next

Send PM Follow Ignore

Followers	507
Posts	10138
Boards Moderated	0
Alias Born	04/28/2014

stocktrademan

Re: None

Tuesday, 11/28/2017 1:04:36 PM

Tuesday, November 28, 2017 1:04:36 PM

BNTC buy 3.0400

double bottom
sideways triangle breakout
gap up
good volume
macd zero crossup
macd histogram crossup
moving average 'golden cross' pattern

normal chart

log chart

Keep Last Read

Next 10 Prev Next

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:

Detailed Quote

Recent BNTC News

Form 8-K - Current report • Edgar (US Regulatory) • 03/08/2024 09:17:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:13:15 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 03/08/2024 09:12:19 PM
Form EFFECT - Notice of Effectiveness • Edgar (US Regulatory) • 03/06/2024 05:15:18 AM
Form DEL AM - Delaying amendment • Edgar (US Regulatory) • 02/26/2024 02:06:56 PM
Form S-3 - Registration statement under Securities Act of 1933 • Edgar (US Regulatory) • 02/23/2024 09:09:24 PM
Form 8-K - Current report • Edgar (US Regulatory) • 02/13/2024 01:15:31 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 02/13/2024 01:01:16 PM
Form 8-K - Current report • Edgar (US Regulatory) • 12/07/2023 09:15:54 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/30/2023 12:31:00 PM
Benitec Biopharma to Participate in a Fireside Chat at the 35th Annual Piper Sandler Healthcare Conference • GlobeNewswire Inc. • 11/17/2023 01:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 11/13/2023 01:03:01 PM
Form 10-Q - Quarterly report [Sections 13 or 15(d)] • Edgar (US Regulatory) • 11/13/2023 01:00:49 PM
Benitec Biopharma Releases First Quarter 2024 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 11/13/2023 01:00:00 PM
Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material • Edgar (US Regulatory) • 10/20/2023 08:31:26 PM
Form DEF 14A - Other definitive proxy statements • Edgar (US Regulatory) • 10/20/2023 10:04:42 AM
Form 8-K - Current report • Edgar (US Regulatory) • 10/16/2023 09:29:59 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/28/2023 09:19:02 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/21/2023 12:05:29 PM
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405] • Edgar (US Regulatory) • 09/21/2023 12:00:53 PM
Benitec Biopharma Releases Full Year 2023 Financial Results and Provides Operational Update • GlobeNewswire Inc. • 09/21/2023 12:00:00 PM
Form 8-K - Current report • Edgar (US Regulatory) • 09/18/2023 09:26:00 PM
Form 4 - Statement of changes in beneficial ownership of securities • Edgar (US Regulatory) • 08/14/2023 09:13:45 PM
Form 8-K - Current report • Edgar (US Regulatory) • 08/11/2023 08:01:00 PM
Benitec Biopharma Inc. Announces Closing of $30 Million Underwritten Public Offering • GlobeNewswire Inc. • 08/11/2023 05:00:12 PM

More BNTC News

InvestorsHub NewsWire

UC Asset Expected to Report $0.03/share Net Profit for 2023 • UCASU • Apr 11, 2024 10:00 AM

Kona Gold Beverages & Apple Rush Co. Execute Joint Venture & Manufacturing Agreement • APRU • Apr 11, 2024 9:40 AM

VAYK Confirmed Its Eligibility for $1.8 Million Investment through Federal EB5 Program • VAYK • Apr 11, 2024 9:00 AM

ILUS Moves Forward With Its Two Subsidiary Uplists and Equity Dividend • ILUS • Apr 10, 2024 9:36 AM

Quartz Intersects 102m of 2.22 g/t Au and 104 g/t Ag Announces New Discovery at Prodigy on its Maestro Project, British Columbia • QZM • Apr 10, 2024 8:00 AM

Swifty Global Announces Record Annual Results Ahead of National Exchange Reverse Merger • DRCR • Apr 9, 2024 1:55 PM

Start posting your company's news

Only $200 per official company press release!

Volume
Day Range:
Bid Price
Ask Price
Last Trade Time:

Boards:

Quotes:

Boards

News

Market Data

Markets

Discover